• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

dementia

Rippl Secures $23M to Expand its Virtual Dementia Care Platform

by Fred Pennic 10/02/2024 Leave a Comment

Rippl Secures $23M to Expand its Virtual Dementia Care Platform

What You Should Know:  - Rippl, a provider of virtual dementia care raises $23M ina Series A funding round led by Tina Hoang-To, Founding General Partner at Kin Ventures, with participation from existing investors including ARCH Venture Partners, General Catalyst, GV (Google Ventures), F-Prime, Mass General Brigham Ventures, and 1843 Capital. JSL Health also joined the round as a new investor. - The need for accessible and compassionate dementia care is more critical than ever. With
Read More

ALZpath Secures Funding for Blood-Based Biomarker Testing for Alzheimer’s Disease Detection

by Fred Pennic 07/21/2023 Leave a Comment

ALZpath Secures Funding for Blood-Based Biomarker Testing for Alzheimer's Disease Detection

What You Should Know:  - ALZpath, a developer of blood-based diagnostic biomarker testing for Alzheimer's disease detection receives funding from the Alzheimer’s Drug Discovery Foundation (ADDF)’s Diagnostics Accelerator to accelerate the clinical availability  of ALZpathDx as a laboratory developed test (LDT).  - ALZpathDx is a novel, proprietary assay for blood-based measurement of phosphorylated tau at threonine 217 (pTau217), a highly accurate, diagnostic biomarker for
Read More

 Are Hospitals Ready for Alzheimer’s Treatment Approval?

by John Showalter, MD, Chief Product Officer at Linus Health 03/20/2023 Leave a Comment

 Are Hospitals Ready for Alzheimer's Treatment Approval?

The FDA’s recent accelerated approval of Leqembi was welcome news across the Alzheimer’s community. However, few health systems, medical practices, or providers are prepared for the extraordinary public interest in a treatment for Alzheimer’s disease – especially not one targeting mild cognitive impairment (MCI) and early dementia due to Alzheimer’s disease – that is likely headed their way soon. The unprecedented scale of the public health and marketing campaigns, the high prevalence of MCI in
Read More

Blood Sugar Monitoring Devices Pose Wearability & Use Problems for Older Diabetic Adults & Caregivers

by Syed Hamza Sohail 02/09/2023 Leave a Comment

Blood Sugar Monitoring Devices Pose Wearability & Use Problems for Older Diabetic Adults & Caregivers

What You Should Know: - In an initial trial of continuous glucometer use, faulty device adhesive -- a serious wearability challenge -- and patient difficulty in interpreting graphs produced by the device, were noted. In a subsequent trial, 70 older adults with diabetes wore glucometers and activity monitors and used smartphones and electronic medication bottles to track and manage blood sugar over a two-week period. - Among these 70 patients, two-thirds of whom were African American and
Read More

The Continuing Rise of AI in the Healthcare Sector in 2023

by Melissa Powell, COO of Genesis HealthCare 01/11/2023 Leave a Comment

The Continuing Rise of AI in the Healthcare Sector in 2023

The announcement in September 2022 that the health tech company Iodine Software was entering into a partnership with the software platform TruCode “to upend clinical administration using artificial intelligence” serves as one of the more recent reminders of AI’s considerable impact on the healthcare sector. Certainly, it will be felt not just in the administrative realm, but also in the clinical and operational aspects as well. And given the challenges presented by a rapidly aging population,
Read More

The Evolution from Hearing Aids to Wellness Devices

by Brian Taylor, AuD, Sr. Director of Audiology for Signia 01/03/2023 Leave a Comment

The Evolution from Hearing Aids to Wellness Devices

Here’s what we know from decades of research: Hearing loss affects health and well-being, but people with hearing loss are often reluctant to wear hearing aids. Of course, they’re doing themselves no favors. But when they do finally opt for hearing assistance (on average, about seven years after they learn they need it), we also now know that the longer people wear hearing aids — throughout the day, for instance, rather than just in certain situations — the healthier they tend to be. Better
Read More

Real-World Study Uses AI to Identify Undiagnosed Dementia in Primary Care

by Syed Hamza Sohail 12/28/2022 Leave a Comment

Real-World Study Uses AI to Identify Undiagnosed Dementia in Primary Care

What You Should Know: - Rising to meet the formidable challenge of the timely diagnosis of dementia, research scientists from Regenstrief Institute, IUPUI and the medical schools of Indiana University and the University of Miami are conducting the Digital Detection of Dementia study, a real-world evaluation of the use of an artificial intelligence (AI) tool they developed for early identification of Alzheimer’s disease and related dementias in primary care, the setting where most adults
Read More

Why The Future of Lateral Flow Testing is Digital

by Christa Schnider, Business Development Director, Jabil Healthcare 12/28/2022 Leave a Comment

Why The Future of Lateral Flow Testing is Digital

Lateral flow immunoassay tests (or LFTs, for short) have been in use for decades, becoming an indispensable tool within diagnostics’ (Dx) practice, as well as a growing range of applications outside healthcare. LFT's capacity for delivering fast turnaround—rapid detection in less than 20 minutes—from sample to result has made LFTs central to the shift moving triage and primary care closer to the patient at point-of-care (POC) and point-of-need (PON).  Being intuitive for the user,
Read More

Walgreens Find Care Offers Dementia Patients with Personalized Playlists

by Fred Pennic 12/16/2022 Leave a Comment

Walgreens Find Care Offers Dementia Patients with Personalized Playlists

What You Should Know: - Music Health Inc. announced that its music wellness app, Vera, is now available through Walgreens Find Care® to provide people living with different forms of dementia with convenient and affordable access to personalized music from their computers and smart devices. - Vera is a new app that supports caregivers by offering the person in their care a custom-made “soundtrack of their lives” that can
Read More

RSNA: NVIDIA Partners With NHS Trusts to Deploy AI Platform in UK Hospitals

by Syed Hamza Sohail 11/28/2022 Leave a Comment

NVIDIA Partners With NHS Trusts to Deploy AI Platform in UK Hospitals

What You Should Know: - A consortium of 10 National Health Service Trusts — the publicly funded healthcare system in England — is now deploying the MONAI-based AIDE platform across four of its hospitals, providing artificial intelligence (AI)-enabled disease-detection tools to healthcare professionals serving 5 million patients a year.  - AIDE, short for AI Deployment Engine, is expected to be rolled out next year across 11 NHS hospitals serving 18 million patients, bringing AI
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |